,title,source,link,date
0,USFDA gives tentative approval to Lupin’s Type 2 diabetes drug,The Financial Express,news.google.com/articles/CBMihAFodHRwczovL3d3dy5maW5hbmNpYWxleHByZXNzLmNvbS9oZWFsdGhjYXJlL3BoYXJtYS1oZWFsdGhjYXJlL3VzZmRhLWdpdmVzLXRlbnRhdGl2ZS1hcHByb3ZhbC10by1sdXBpbnMtdHlwZS0yLWRpYWJldGVzLWRydWcvMzMxNTk0NC_SAYkBaHR0cHM6Ly93d3cuZmluYW5jaWFsZXhwcmVzcy5jb20vaGVhbHRoY2FyZS9waGFybWEtaGVhbHRoY2FyZS91c2ZkYS1naXZlcy10ZW50YXRpdmUtYXBwcm92YWwtdG8tbHVwaW5zLXR5cGUtMi1kaWFiZXRlcy1kcnVnLzMzMTU5NDQvbGl0ZS8?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
6,Lupin gets USFDA nod for its solution to treat ocular pain,The Financial Express,news.google.com/articles/CBMigQFodHRwczovL3d3dy5maW5hbmNpYWxleHByZXNzLmNvbS9oZWFsdGhjYXJlL3BoYXJtYS1oZWFsdGhjYXJlL2x1cGluLWdldHMtdXNmZGEtbm9kLWZvci1pdHMtc29sdXRpb24tdG8tdHJlYXQtb2N1bGFyLXBhaW4vMzMxNTg2MS_SAYYBaHR0cHM6Ly93d3cuZmluYW5jaWFsZXhwcmVzcy5jb20vaGVhbHRoY2FyZS9waGFybWEtaGVhbHRoY2FyZS9sdXBpbi1nZXRzLXVzZmRhLW5vZC1mb3ItaXRzLXNvbHV0aW9uLXRvLXRyZWF0LW9jdWxhci1wYWluLzMzMTU4NjEvbGl0ZS8?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
63,"Global Olanzapine Market 2023 Business Outlook, Share Analysis, Key Drivers And Forecast To 2032 | Major Playe",openPR,news.google.com/articles/CBMiWGh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMzAxMTg2L2dsb2JhbC1vbGFuemFwaW5lLW1hcmtldC0yMDIzLWJ1c2luZXNzLW91dGxvb2stc2hhcmXSAVdodHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMzAxMTg2L2dsb2JhbC1vbGFuemFwaW5lLW1hcmtldC0yMDIzLWJ1c2luZXNzLW91dGxvb2stc2hhcmU?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
27,The blurring of lines: A review of Lupin season 3,Epigram,news.google.com/articles/CBMiX2h0dHBzOi8vZXBpZ3JhbS5vcmcudWsvMjAyMy8xMS8yNC90aGUtYmx1cnJpbmctb2YtbGluZXMtYS1yZXZpZXctb2Ytc2Vhc29uLTMtbmV0ZmxpeC1oaXQtbHVwaW4v0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
23,"Share Market Highlights 24 November 2023: Indices trade flat, Nifty settles below 19,800",BusinessLine,news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9tYXJrZXRzL3N0b2NrLW1hcmtldC1oaWdobGlnaHRzLTI0LW5vdmVtYmVyLTIwMjMvYXJ0aWNsZTY3NTY1NDQ4LmVjZdIBbmh0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9tYXJrZXRzL3N0b2NrLW1hcmtldC1oaWdobGlnaHRzLTI0LW5vdmVtYmVyLTIwMjMvYXJ0aWNsZTY3NTY1NDQ4LmVjZS9hbXAv?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
9,"Buzzing Stocks: TCS, Lupin, HDFC Bank, Siemens, Power Finance, JSW Steel, others in news",Moneycontrol,news.google.com/articles/CBMimAFodHRwczovL3d3dy5tb25leWNvbnRyb2wuY29tL25ld3MvcGhvdG9zL2J1c2luZXNzL3N0b2Nrcy9idXp6aW5nLXN0b2Nrcy10Y3MtbHVwaW4taGRmYy1iYW5rLXNpZW1lbnMtcG93ZXItZmluYW5jZS1qc3ctc3RlZWwtb3RoZXJzLWluLW5ld3MtMTE4MDIxMzEuaHRtbNIBnAFodHRwczovL3d3dy5tb25leWNvbnRyb2wuY29tL25ld3MvcGhvdG9zL2J1c2luZXNzL3N0b2Nrcy9idXp6aW5nLXN0b2Nrcy10Y3MtbHVwaW4taGRmYy1iYW5rLXNpZW1lbnMtcG93ZXItZmluYW5jZS1qc3ctc3RlZWwtb3RoZXJzLWluLW5ld3MtMTE4MDIxMzEuaHRtbC9hbXA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
83,"Stocks to Watch: Cipla, Apar Industries, Indian Hotels, NMDC, L&T Finance and more",CNBCTV18,news.google.com/articles/CBMidGh0dHBzOi8vd3d3LmNuYmN0djE4LmNvbS9tYXJrZXQvc3RvY2tzLXRvLXdhdGNoLWNpcGxhLWFwYXItaW5kdXN0cmllcy1ubWRjLWluZGlhbi1ob3RlbHMtbHVwaW4tYW5kLW1vcmUtMTgzOTk5ODEuaHRt0gF4aHR0cHM6Ly93d3cuY25iY3R2MTguY29tL21hcmtldC9zdG9ja3MtdG8td2F0Y2gtY2lwbGEtYXBhci1pbmR1c3RyaWVzLW5tZGMtaW5kaWFuLWhvdGVscy1sdXBpbi1hbmQtbW9yZS0xODM5OTk4MS5odG0vYW1w?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
3,Lupin Ltd.’s shares up on approval for Canagliflozin & Bromfenac Ophthalmic,BusinessLine,news.google.com/articles/CBMiiAFodHRwczovL3d3dy50aGVoaW5kdWJ1c2luZXNzbGluZS5jb20vbWFya2V0cy9sdXBpbi1sdGRzLXNoYXJlcy11cC1vbi1hcHByb3ZhbC1mb3ItY2FuYWdsaWZsb3ppbi1icm9tZmVuYWMtb3BodGhhbG1pYy9hcnRpY2xlNjc1Njg2ODkuZWNl0gGNAWh0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9tYXJrZXRzL2x1cGluLWx0ZHMtc2hhcmVzLXVwLW9uLWFwcHJvdmFsLWZvci1jYW5hZ2xpZmxvemluLWJyb21mZW5hYy1vcGh0aGFsbWljL2FydGljbGU2NzU2ODY4OS5lY2UvYW1wLw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
5,USFDA approves Lupin Bromfenac Ophthalmic Solution,Medical Dialogues,news.google.com/articles/CBMiamh0dHBzOi8vbWVkaWNhbGRpYWxvZ3Vlcy5pbi9uZXdzL2luZHVzdHJ5L3BoYXJtYS91c2ZkYS1hcHByb3Zlcy1sdXBpbi1icm9tZmVuYWMtb3BodGhhbG1pYy1zb2x1dGlvbi0xMjA2NDLSAW5odHRwczovL21lZGljYWxkaWFsb2d1ZXMuaW4vYW1wL25ld3MvaW5kdXN0cnkvcGhhcm1hL3VzZmRhLWFwcHJvdmVzLWx1cGluLWJyb21mZW5hYy1vcGh0aGFsbWljLXNvbHV0aW9uLTEyMDY0Mg?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
2,Lupin shares near 52-week high after drug maker receives two approvals from US regulator,Zee Business,news.google.com/articles/CBMijwFodHRwczovL3d3dy56ZWViaXouY29tL21hcmtldHMvc3RvY2tzL25ld3MtbHVwaW4tc2hhcmVzLW5lYXItNTItd2Vlay1oaWdoLWFmdGVyLWRydWctbWFrZXItcmVjZWl2ZXMtdHdvLWFuZGEtYXBwcm92YWxzLWZyb20tdXMtcmVndWxhdG9yLTI2NTk1NNIBkwFodHRwczovL3d3dy56ZWViaXouY29tL21hcmtldHMvc3RvY2tzL25ld3MtbHVwaW4tc2hhcmVzLW5lYXItNTItd2Vlay1oaWdoLWFmdGVyLWRydWctbWFrZXItcmVjZWl2ZXMtdHdvLWFuZGEtYXBwcm92YWxzLWZyb20tdXMtcmVndWxhdG9yLTI2NTk1NC9hbXA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-24
